What the company does
L&K Biomed makes spinal implants, metal screws, plates, and cages surgically inserted into the spine to stabilize or correct conditions such as degeneration, stenosis, fractures, and scoliosis.
Its products are used by orthopedic and neurosurgeons and fall into the highest-risk regulated category for implantable medical devices in Korea. Listed on KOSDAQ, Korea's tech and small-cap board, the company covers the full product range for spinal surgery, spanning both cervical (neck) and thoracolumbar (mid-to-lower back) applications.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue · FY2025
US$28.2M
▲ +7.8% YoY
Operating profit · FY2025
US$518.2K
▼ −76.8% YoY
Net income · FY2025
−US$12.2M
Turned to loss
Revenue
- FY2023US$21.7M
- FY2024US$26.2M
- FY2025US$28.2M
Operating profit
- FY2023US$1.5M
- FY2024US$2.2M
- FY2025US$518.2K
Net income
- FY2023−US$3.8M
- FY2024US$6.6M
- FY2025−US$12.2M
Key ratios (FY2025)
ROE
-43.5%
Debt/Eq
116.1%
Op. margin
1.8%
Net margin
-43.1%
Rev. YoY
▲ +7.8%
Price charts coming soon
Interactive price history isn't here yet. Would you use it?